← Evidence map

ArticlePharmaceutical biology2021

Targeting CD155 by rediocide-A overcomes tumour immuno-resistance to natural killer cells.

Wanyi Ng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

10 papers cite it

2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 33399495